ARA BIOGEARS(R) OPEN SOURCE HUMAN PHYSIOLOGY ENGINE

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ARA BIOGEARS(R) OPEN SOURCE HUMAN PHYSIOLOGY ENGINE SHOWCASE AT IMSH 2015

NEW ORLEANS, Jan. 8, 2015 (GLOBE NEWSWIRE) -- INTERNATIONAL MEETING ON SIMULATION IN HEALTHCARE ( IMSH ) – From January 10-14, 2015 Applied Research Associates (ARA, www.ara.com ) is showcasing BioGears ® ( www.biogearsengine.com ) at IMSH 2015 in the government agency R &D Exhibit Showcase, Booth C. IMSH 2015 is the 15 th annual premier educational and networking event for healthcare simulation professionals from all disciplines.

BioGears ® delivers an open source, comprehensive, extensible human physiology engine that serves as a platform for biomedical modeling research and also facilitates the creation of immersive medical education and training technologies. At IMSH, the BioGears ® team will interact with over 2,000 professionals from around the globe who will see the latest in technology advancements, attend hands-on workshops and explore professional development opportunities.

The IMSH showcase will inform the public regarding developments within the military medical simulation community, and demonstrate the utility of BioGears ® to civilian and military healthcare training professionals. The current release of BioGears ® is available for download via an Apache 2.0 open source license and can be used for commercial product development and both government and academic research efforts. If you are interested in the BioGears ® program and plan to attend IMSH 2015, please stop by our booth or contact us to set up a meeting with our team.

In October 2014, the BioGears ® Mini Build was released to the public. The current version of the software includes cardiovascular and respiratory system models, a range of virtual patient insults, interventions, and assessments, and full documentation. BioGears ® also provides an API for real-time retrieval of accurate physiology state that allows for easy integration with both immersive medical simulation software and manikins.

In the Fall of 2015, the BioGears ® team will release a software Beta build which will be a whole body simulation comprised of multiple system-level models, including cardiovascular, respiratory, renal, energy balance, endocrine, environment, and substance transport. It will also include Pharmacokinetic/Pharmacodyanmic (PK/PD) and gas exchange models, assessments such as blood and urine panels, electrocardiogram (ECG), and a Pulmonary Function Test (PFT). Following the Beta release, the BioGears ® team will hold a free conference in the Raleigh-Durham, NC area to discuss model extensions with the user community, exhibit research projects that use BioGears ® , and provide tutorials for content developers, integrators, and modelers.

BioGears ® is a $7M, multi-year program funded by the Defense Medical Research Development Program (DMRDP) and administered by the U.S. Army's Telemedicine & Advanced Technology Research Center (TATRC), Armed Forces Simulation Institute for Medicine (AFSIM), under USAMRMC award number W81XWH-13-2-0068.

To learn more about using BioGears ® or partnering with ARA's BioGears ® research team on upcoming projects, please contact us .

About Applied Research Associates, Inc. (ARA) :

Applied Research Associates, Inc. (ARA) is an international research and engineering company recognized for providing technically excellent solutions to complex and challenging problems in the physical sciences. Our mission is to provide in-depth and diversified research, engineering, and technical support services. We have a broad range of technical expertise in biomedical engineering, defense technologies, civil engineering, computer software and simulation, systems analysis and environmental technologies. ARA's biomedical modeling and simulation research group has a proven track record of creating innovative, physiologically accurate mathematical models that drive immersive, game-based medical training technologies. For additional information, please visit: www.ara.com .

A photo accompanying this release is available at:

http://www.globenewswire.com/newsroom/prs/?pkgid=29936

Jenn Carter | | 919.582.3438 | www.ara.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 39

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 116

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 385

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading

Top 5 Most Recently Viewed Articles

IONQ Achieves Record Stock Levels Amid Strong Growth Indicators

Updated Category News Views 243

IONQ Stock Reaches New Heights Recently, IONQ has made headlines as its stock skyrocketed to an unprecedented level of $47.41, marking a significant achievement for the company. With a robust market capitalization of $10.2 billion, this remarkable performance is a testament to the company's impressive growth trajectory and the strong belief investors hold in its future....

Continue Reading
Model 1 Commercial Vehicles Expands Leadership Team for Growth

Updated Category News Views 285

Model 1 Commercial Vehicles Announces Leadership Changes Model 1 Commercial Vehicles is thrilled to unveil a set of key leadership appointments aimed at enhancing its strategic direction and ensuring the company's ongoing success. These changes reflect the impressive growth trajectory the company has experienced over the past few years. Tony Matijevich Takes the Helm as...

Continue Reading
Texas Instruments: Unusual Options Trends Uncovered

Updated Category News Views 195

Texas Instruments Options Insights Financial powerhouses have made a notable bullish move on Texas Instruments. Our analysis reveals intriguing trends within the options market for Texas Instruments (NASDAQ: TXN), showcasing an unusual number of trades that pinpoint shifting market sentiments. Trading Sentiment Overview Diving deeper into the data, it appears that 58% of...

Continue Reading
SMCP Unveils Latest Interim Financial Report for 2025

Updated Category News Views 177

SMCP Announces Availability of Its Interim Financial Report SMCP is excited to share that its interim financial report for the six-month period ending June 30, 2025, is now available for public access. This report has been officially filed with the relevant regulatory authorities. Details on the Financial Report This financial report outlines the company's performance...

Continue Reading
Kevin O'Leary Discusses Business Leaders' Support for Trump

Updated Category News Views 159

Understanding O'Leary's Perspective on Business Leadership Kevin O’Leary, a prominent entrepreneur and investor from Shark Tank, has provided insight into the evolving relationship between business leaders and President Trump. In recent discussions, O’Leary emphasized that the admiration many tech CEOs and corporate leaders have for Trump is not solely about his tax...

Continue Reading